Erkut Ozturk
Boston Children's Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Erkut Ozturk.
Pediatrics International | 2012
Ozgur Kizilca; Rengin Siraneci; Alev Yilmaz; Nevin Hatipoglu; Erkut Ozturk; Aysel Kiyak; Dilek Ozkok
The aim of the present study was to investigate the risk factors of antimicrobial resistance in children with urinary tract infection caused by extended‐spectrum beta‐lactamase (ESBL)‐producing bacteria.
Pacing and Clinical Electrophysiology | 2016
Pelin Ayyıldız; Taner Kasar; Erkut Ozturk; Isa Ozyilmaz; Ibrahim Cansaran Tanidir; Alper Guzeltas; Yakup Ergül
The features of pediatric patients with postoperative transient and permanent complete atrioventricular (AV) block (CAVB) were compared.
Pacing and Clinical Electrophysiology | 2015
Yakup Ergül; Serkan Unsal; Isa Ozyilmaz; Erkut Ozturk; Hayat Carus; Alper Guzeltas
Dexmedetomidine (DEX) is a highly selective alpha‐2‐adrenergic agonist approved for short‐term sedation and monitored anesthesia care in adults. Its effects on the electrocardiography and cardiac conduction tissue are not well described in the literature. Therefore, we aimed to characterize the electrocardiographic and electrophysiologic effects of DEX in children.
Pediatrics International | 2014
Erkut Ozturk; Ibrahim Cansaran Tanidir; Murat Saygi; Yakup Ergül; Alper Guzeltas; Ender Odemis
The aim of this study was to examine the causes of cardiac tamponade in children undergoing percutaneous pericardiocentesis.
Cardiology in The Young | 2014
Isa Ozyilmaz; Yakup Ergül; Celal Akdeniz; Erkut Ozturk; Ibrahim Cansaran Tanidir; Tuzcu
OBJECTIVES Curative therapy of idiopathic ventricular tachycardia remains a challenge in interventional electrophysiology. The aim of this study was to demonstrate the utility of an EnSite NavX system in the catheter ablation of idiopathic ventricular tachycardia in children. PATIENTS AND METHODS In all, 17 children with idiopathic ventricular tachycardia underwent electrophysiological studies using the EnSite NavX system guidance. RESULTS The mean patient age was 13 ± 2.4 years (range: 7.8-17.9) and the mean patient weight was 52.3 ± 11.9 kg (range: 32-75). The origin of ventricular tachycardia was in the right ventricular outflow tract in nine patients, in the left ventricle in six, near the bundle of His/right bundle branch in one, and in the left aortic cusp in one. The mean procedure and fluoroscopy times were 169.3 ± 43.2 minutes and 8 ± 10.8 minutes, respectively. No fluoroscopy was used in six patients. The mean radiation exposure was 33.1 ± 56.4 mGy. Acute success was achieved in 14 patients (82%). The focus of ventricular tachycardia was epicardial in two failed procedures. During a mean follow-up of 8.5 ± 7.6 months, ventricular tachycardia recurred in three patients, two of whom underwent a second procedure. Except for one patient who developed transient right bundle branch block, no complications were seen. CONCLUSION Catheter ablation of idiopathic ventricular tachycardia in children can be performed safely and effectively with low fluoroscopy exposure using the EnSite NavX system.
Pediatrics International | 2015
Murat Saygi; Yakup Ergül; Hasan Tahsin Tola; Isa Ozyilmaz; Erkut Ozturk; Ismihan Selen Onan; Sertac Haydin; Ersin Erek; Mehmet Yeniterzi; Alper Guzeltas; Ender Odemis; Ihsan Bakir
We evaluated the preoperative, operative and postoperative risk factors affecting early mortality in patients who underwent total correction of tetralogy of Fallot (TOF).
Artificial Organs | 2014
Ibrahim Cansaran Tanidir; Erkut Ozturk; Isa Ozyilmaz; Murat Saygi; Neslihan Kiplapinar; Sertac Haydin; Alper Guzeltas; Ender Odemis
Near-infrared spectroscopy (NIRS) is a noninvasive method used to evaluate tissue oxygenation. We evaluated the relationship between cerebral and renal NIRS parameters during transcatheter intervention and adverse events in the catheterization room. Between January 1 and May 31, 2012, 123 of 163 pediatric patients undergoing cardiac catheterization were followed by NIRS. All were monitored by electrocardiography, noninvasive blood pressure measurement, pulse oxymetry, initial and final blood lactate level measurement. The number of interventional procedures was 73 (59%). During the procedures, 39 patients experienced a total of 41 adverse events: 18 (19.5%) had desaturation, 10 (8.1%) arrhythmia, three (2.4%) had respiratory difficulty, six (4.8%) had a situation calling for cardiopulmonary resuscitation, three (2.4%) had anemia necessitating transfusion, and one (0.8%) had a cyanotic spell. Cranial NIRS values worsened in 12 (9.8%) and renal measurements worsened in 13 (12.5%) patients. The sensitivity and specificity of a 9% impairment of cranial values were 90 and 61%, respectively, while the corresponding calculations for a 21% fall in renal measurements were 54% sensitivity and 90% specificity. When arrhythmia developed, NIRS values fell simultaneously, while the development of a desaturation problem was heralded by NIRS falling 10-15 s earlier than changes in pulse oxymetry; on improving saturation, NIRS returned to earlier values 10-15 s before pulse oxymetry readings. NIRS monitoring may provide an early warning with regard to complications likely to develop during a procedure. A fall of 9% in cranial NIRS values, or of 21% in renal measurements, should raise clinician awareness.
Cardiology in The Young | 2014
Erkut Ozturk; Ibrahim Cansaran Tanidir; Sertac Haydin; Ismihan Selen Onan; Ender Odemis; Ihsan Bakir
OBJECTIVE To investigate the efficacy of dornase alpha, a mucolytic agent, in children who developed pulmonary atelectasis after congenital heart surgery. DESIGN Retrospective case-control study. SETTING Paediatric cardiac intensive care unit at a tertiary care hospital. PATIENTS Between July, 2011 and July, 2012, 41 patients who underwent congenital cardiac operations and developed post-operative pulmonary atelectasis that was resistant to conventional treatment and chest physiotherapy. INTERVENTIONS In all, 26 patients received dornase alpha treatment. As a control group, 15 patients were treated with conventional medications and chest physiotherapy. MAIN RESULTS The median age of patients was 25.5 (3-480) days in the study group and 50.0 (3-480) days in the control group. A total of 15 (57.6%) patients in the study group and 8 (53.3%) patients in the control group were male. The median weight was 4.2 (2.9-14.2) kg and 4.0 (3.5-13.6) kg in the study and control group, respectively. In the study group, pulmonary atelectasis was diagnosed at a median period of 5 (2-18) days after operations, whereas in the control group atelectasis was diagnosed at a median period of post-operative 6 (3-19) days. In the study group, the median atelectasis score decreased from 3.4 (1-6) to 0.8 (0-3) (p = 0.001). The median pO2 level increased from 69 (17-142) mmHg to 89 (30-168) mmHg (p = 0.04). In addition, heart rate and respiratory rate per minute were significantly decreased (p < 0.05). There were no significant changes in these parameters in the control group. CONCLUSIONS The use of dornase alpha can be effective for the management of pulmonary atelectasis that develops following congenital heart surgery.
Congenital Heart Disease | 2015
Yakup Ergül; Erkut Ozturk; Isa Ozyilmaz; Serkan Unsal; Hayat Carus; Hasan Tahsin Tola; Ibrahim Cansaran Tanidir; Alper Guzeltas
BACKGROUND We aimed to determine the correlation between noninvasive testing (exercise stress testing [EST] and adenosine responsiveness of accessory pathway [AP] ) and invasive electrophysiology study (EPS) for assessment antegrade conduction of the AP in Wolff-Parkinson-White syndrome. PATIENTS AND METHOD This prospective, observational study enrolled 40 children (58% male children, median age of 13 years, and median weight of 47.5 kg) with Wolff-Parkinson-White syndrome. Conduction through the AP to a cycle length of ≤250 ms was considered rapid or high-risk; otherwise, patients were nonrapid or low-risk. RESULTS The sudden disappearance of the delta-wave was seen in 10 cases (25%) during EST. Accessory pathway was found to be high-risk in 13 cases (13/40, 32.5%) while the accessory path was identified as low-risk in 27 cases; however, six patients (15%) had blocked AP conduction with adenosine during EPS. Low-risk classification by EST alone to identify patients with nonrapid conduction in baseline EPS had a specificity of 93% and a positive predictive value of 90% (accuracy 54%). Blocked AP conduction with adenosine as a marker of nonrapid baseline AP conduction had a specificity of 93% and a positive predictive value of 84%. Finally, AP was adenosine nonresponsive in the majority of patients (28/30, 93%) with persistent delta-waves, 40% of those who had a sudden disappearance of delta-waves had an adenosine-responsive AP (P value: .028). CONCLUSION Abrupt loss of preexcitation during EST and blocked AP conduction with adenosine had high specificity and positive predictive value for nonrapid and low-risk antegrade conduction during baseline invasive EPS. Successful risk stratification of pediatric patients with Wolff-Parkinson-White is possible through the use of EST and the adenosine responsiveness of AP.
Anatolian Journal of Cardiology | 2015
Isa Ozyilmaz; Yakup Ergül; Hasan Tahsin Tola; Murat Saygi; Erkut Ozturk; Ibrahim Cansaran Tanidir; Öykü Tosun; Sinem Özyılmaz; Mehmet Gul; Alper Guzeltas; Ender Odemis; Ihsan Bakir
Objective: We evaluated autonomic behavior by examining heart rate variability (HRV) in the time domain and frequency domain in pediatric patients who underwent transcatheter closure of atrial septal defect (ASD). Methods: A prospective study design was used. Holter ECG was performed in a control group of 30 healthy subjects and a group of 47 patients who underwent transcatheter ASD closure. ECG was taken one day before, one day after, and six months after the procedure to evaluate changes in the time domain [SDNN, rMSSD, NN, pNN50(%), and SDANN] and frequency domain (VLF, LF, HF, VHF, and LF/HF) in the patient group. Student’s t-test was used to evaluate changes prior to and after the procedure. Results: There were 28 females (60%) in the patient group and 21 females (70%) in the control group. The mean age and weight of the participants in the patient group were 9.61±4.72 years and 32.40±19.60 kg, respectively; the mean age and weight of the control subjects were 10.43±5.31 years and 32.83±13.00 kg, respectively. In both the time domain and frequency domain analyses, the patient group values were found to be lower than those in the control group prior to the procedure; the values in the patient group were found to approach the values in the control group following the procedure. By the sixth month, the values in the patient group reached the control levels with no statistically significant difference (SDNN: 145±0.84, 137.50±42.50; r MSSD: 72.18±48.22, 58.14±28.49; SDANN: 125.13±13.50, 122.40±41.06; VLF: 112.85±29.07, 114.41±98.39; LF: 50.40±24.09, 45.69±15.13; HF: 39.28±19.86, 44.29±13.14; VHF: 10.29±4.24, 9.99±6.47; LF/HF: 1.90±1.44, 1.24±0.81; p>0.05). Conclusion: The transcatheter closure of secundum ASDs was found to have a positive effect on HRV. Consequently, it may contribute to reduced mortality and morbidity. We can conclude that in children, HRV recovers approximately six months after transcatheter ASD closure.